Webb10 mars 2024 · PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2024. “Oxford Immunotec’s global role in fighting tuberculosis, particularly its trademark product, the T-SPOT®.TB test, and the operations it has built are remarkable,” said Prahlad Singh, PerkinElmer president and chief executive officer. WebbOxford Immunotec has taken the classic ELISPOT methodology and developed it into the T-SPOT ® technology platform, which is used by Certimmune. Unlike other technologies, …
Chris Allen - IT Manager - Oxford Immunotec LinkedIn
Webb11 jan. 2024 · Oxford Immunotec at a Glance Headquartered in Abingdon, the U.K., Oxford Immunotec is a global, high-growth diagnostics company, leader in proprietary test kits for latent tuberculosis. The... WebbT-SPOT and the Oxford Immunotec logo are registered trademarks of Oxford Immunotec Ltd. © 2024 Oxford Immunotec. All rights reserved. orange hairs
Oxford Immunotec Company Profile - Craft
Webb19 maj 2024 · Oxford Immunotec Global PLC, a global, high-growth diagnostics company, today announces the release of the T-SPOT Discovery SARS-CoV-2 test kit. Image … Webb12 mars 2024 · Oxford Immunotec has 5 employees across 22 locations and $73.71 m in annual revenue in FY 2024. See insights on Oxford Immunotec including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. WebbOxford Immunotec releases the T-SPOT Discovery™ SARS-CoV-2 kit 19 May 2024. Product News Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreement 29 Jan 2013. Product News Study results confirm ability of T-SPOT®.TB to detect tuberculosis disease in HIV infected patients orange haired naruto characters